Literature DB >> 18302906

Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30.

Digant Gupta1, James F Grutsch, Christopher G Lis.   

Abstract

Health-related quality of life (QoL) in cancer patients cannot be adequately captured with a single instrument. We compared the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and the Ferrans and Powers Quality of Life Index (QLI). We hypothesized that there would be little overlap among their subscales. Baseline QoL data were collected from a consecutive series of 954 cancer patients treated at our center. Data from the two questionnaires were analyzed on a subscale basis using correlation analysis and the Bland-Altman method. The mean and standard deviations of the difference in QoL subscale scores were used to construct 95% limits of agreement among the subscales. Five hundred seventy-nine were females and 375 were males, with a median age of 52 years. There were poor to modest correlations and poor agreement among the subscales of the two instruments. For QLQ-C30 physical and QLI health, the correlation and limits of agreement were 0.6 and -22.2 to 59.8. For QLQ-C30 role and QLI health, the correlation and limits of agreement were 0.6 and -47.3 to 61.5. For QLQ-C30 social and QLI social, the correlation and limits of agreement were 0.2 and -78.2 to 50.2. Consequently, these instruments measure unrelated aspects of QoL and can give different conclusions.

Entities:  

Mesh:

Year:  2008        PMID: 18302906

Source DB:  PubMed          Journal:  J Soc Integr Oncol        ISSN: 1715-894X


  4 in total

1.  Measuring quality of life of long-term breast cancer survivors: the Long Term Quality of Life-Breast Cancer (LTQOL-BC) Scale.

Authors:  Nahida H Gordon; Laura A Siminoff
Journal:  J Psychosoc Oncol       Date:  2010

2.  Advanced cancer patients in a randomized clinical trial of night-simulating eyeglasses observed to have a normal 24-h circadian rhythm during chemotherapy.

Authors:  Keith I Block; Charlotte Gyllenhaal; James F Grutsch; Penny B Block; Thomas Kazlausky; David Blask; Edward Carome; Justin Reynolds; Dinah Faith Q Huff; William Hrushesky
Journal:  SAGE Open Med       Date:  2022-05-23

3.  Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer.

Authors:  Gwen Wyatt; Alla Sikorskii; Mohammad Hossein Rahbar; David Victorson; Mei You
Journal:  Oncol Nurs Forum       Date:  2012-11       Impact factor: 2.172

4.  The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer.

Authors:  James F Grutsch; Carol Ferrans; Patricia A Wood; Jovelyn Du-Quiton; Dinah Faith T Quiton; Justin L Reynolds; Christine M Ansell; Eun Young Oh; Mary Ann Daehler; Robert D Levin; Donald P Braun; Digant Gupta; Christopher G Lis; William J M Hrushesky
Journal:  BMC Cancer       Date:  2011-05-23       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.